Have $2,000? 2 Remarkable Growth Stocks to Buy Right Now
Regardless of your investing experience or risk tolerance, putting cash into stocks takes a certain tolerance for volatility and uncertainty. No investment has a guaranteed outcome. However, if you have the cash on hand and ability to invest, building a portfolio that stands the test of time doesn't have to be overcomplicated.
Investing in wonderful businesses, diversifying the ones you own, holding onto those great companies through the market's highs and lows, and avoiding traps like market timing can help you outpace the returns of the average retail investor through the years. If you're looking to build out your portfolio of great businesses, here are two names to add to the list for consideration right now.
Pfizer (NYSE: PFE) caught the attention of many investors when it became one of the leading contenders in the race to get a COVID-19 vaccine to market. Now, with a COVID-19 franchise, which includes the vaccine Comirnaty, which it developed with BioNTech, and its antiviral drug Paxlovid that generated about $57 billion in revenue in 2022 alone, investors might be wondering whether the future could contain much more growth for the pharmaceutical giant.
Source Fool.com
Pfizer Inc. Aktie
Die Community bevorzugt Pfizer Inc., mit deutlich mehr Buy- (29) als Sell-Einschätzungen (4).
Ein Kursziel von 41 € für Pfizer Inc. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 28.42 € bedeuten.
